About Tapentadol
Tapentadol was a Healthcare company based in New York (United States) founded in 2020. An online pharmacy specializing in pain-related medications. It operates on a B2C model. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Online Pharmacy and Pain Management. Its competitors include Absorbine Jr, Emu Therapy and Biofreeze.
Company details
Tapentadol, founded in 2020 in New York, United States, focuses on providing healthcare solutions, producing pharmaceutical products, online pharmacy, and pain management. An online pharmacy specializing in pain-related medications. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters New York, United States
- SectorsHealthcare
- Website yourtapentadolonline.com
Competitors of Tapentadol
Tapentadol has 3 listed competitors in our database. They include Absorbine Jr, Emu Therapy and Biofreeze.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| absorbinejr.com | 1998 | Chattanooga, United States | Offers a platform for effective pain relief products. | |||
| emutherapy.com | 2017 | Oklahoma, United States | Provides natural emu oil based pain relief creams and health aids for consumers. | |||
| biofreeze.com | 1997 | Cuyahoga Falls, United States | Developer of cold therapy treatment for pain relief |
Detailed competitors of Tapentadol
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pain Management
3 companies that operate in the same segment as Tapentadol (Pain Management) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of therapeutics for pain relief and inflammatory diseases | 2004 | New York, New York, United States | USD 51 M | USD 4.33 M | 79 | |
GPCR ligand-based therapeutics for cardiovascular diseases and pain are developed. | 2007 | Philadelphia, Pennsylvania, United States | USD 203 M | USD 3.13 M | 35 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tapentadol
Tapentadol was founded in 2020.
Tapentadol is headquartered in New York, United States. It is registered at New York, New York, United States.
Tapentadol, founded in 2020 in New York, United States, focuses on providing healthcare solutions, producing pharmaceutical products, online pharmacy, and pain management. An online pharmacy specializing in pain-related medications. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Tapentadol's top competitors include Biofreeze, Absorbine Jr and Emu Therapy.